End-of-day quote
Other stock markets
|
||
- USD | - |
05-15 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
05-15 | Marker Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar TapImmune Inc.
Upcoming events on TapImmune Inc.
Past events on TapImmune Inc.
2024-05-15 16:15 | Q1 2024 Earnings Release |
2024-04-01 | Hematologic Malignancies Global Summit |
2024-03-26 10:00 | H.C. Wainwright Cell Therapy Virtual Conference |
2024-03-25 17:45 | Q4 2023 Earnings Release |
2024-01-09 | Non Dilutive Funding Summit |
2024-01-07 | Biotech Showcase |
2023-11-09 17:00 | Q3 2023 Earnings Release |
2023-09-13 08:30 | H.C. Wainwright Global Investment Conference |
2023-08-14 16:30 | Q2 2023 Earnings Release |
2023-06-06 09:00 | Annual General Meeting |
2023-03-22 08:10 | Q4 2022 Earnings Release |
2022-11-10 16:05 | Q3 2022 Earnings Release |
2022-09-15 09:20 | Cantor Fitzgerald Cell & Gene Therapy Conference |
2022-08-11 16:22 | Interim 2022 Earnings Release |
2022-05-24 09:00 | Annual General Meeting |
2022-05-13 07:00 | Q1 2022 Earnings Release |
2022-05-05 20:45 | International Society for Cell & Gene Therapy Meeting - Abstract Number : 506 |
2022-05-05 20:45 | International Society for Cell & Gene Therapy Meeting - Abstract Number : 936 |
2022-05-05 20:45 | International Society for Cell & Gene Therapy Meeting - Abstract Number : 515 |
2022-05-05 20:45 | International Society for Cell & Gene Therapy Meeting - Abstract Number : 937 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,21 0,00 - | 0,47 0,48 -3.46% | 1,24 0,00 - | 9,01 9,00 0.15% | 0,00 | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -22,5 -23,2 2.92% | -28,9 -27,8 -3.86% | -39,5 -40,5 2.49% | 0,00 0,00 - | 0,00 | -18,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,4 -22,2 3.26% | -28,7 -27,7 -3.56% | -41,9 -42,3 0.95% | 0,00 0,00 - | -14,0 | -17,4 |
Net income Million USD | Released Forecast Spread | -21,4 -22,2 3.26% | -28,7 -27,7 -3.56% | -41,9 -42,3 0.95% | 0,00 0,00 - | -8,24 | -17,4 |
EPS USD | Released Forecast Spread | -4,70 -4,86 3.29% | -6,10 -5,90 -3.39% | -5,50 -5,73 3.93% | -3,58 -3,60 0.56% | 0,00 | -1,28 |
Announcement Date | 12/03/20 | 09/03/21 | 17/03/22 | 22/03/23 | 25/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,96 0,00 - | 0,79 2,50 -68.38% | 3,95 0,27 1381.07% | 3,31 0,00 - | 1,24 0,00 - | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -9,79 -11,2 12.55% | -9,28 -8,72 -6.46% | -7,02 -11,3 37.7% | -2,55 -2,45 -4.21% | -2,57 | -5,29 | -7,93 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,91 -11,2 11.25% | -9,24 -8,74 -5.81% | -6,92 -10,9 36.23% | -2,39 -2,26 -6.02% | -2,42 | -5,17 | -7,53 | |
Net income Million USD | Released Forecast Spread | -9,91 -11,2 11.25% | -9,24 -8,74 -5.81% | -6,92 -10,9 36.23% | -2,39 -2,26 -6.02% | -2,42 | -5,17 | -7,53 | |
EPS USD | Released Forecast Spread | -1,20 -1,33 10% | -1,10 -1,05 -4.76% | -0,80 -1,30 38.46% | -3,27 -1,00 -227% | -0,27 -0,25 -8% | -0,27 | -0,37 | -0,39 |
Announcement Date | 13/05/22 | 11/08/22 | 10/11/22 | 22/03/23 | 15/05/24 | - | - | - |
2024-07-15 01:45 | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for TapImmune Inc.
2024-05-29 16:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 17:14 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 16:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 16:05 | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- MRKR Stock
- Stock
- Calendar TapImmune Inc.